文献速递关节外科

病态肥胖患者在初次全髋关节置换术的医疗质量改进中是否同等获益?

Are Morbidly Obese Patients Equally Benefitting From Care Improvements in Total Hip Arthroplasty?
PubMed 文献 · J Arthroplasty · 2021-12-06

该研究基于美国外科医师学会国家外科质量改进计划数据库2011至2019年234,334例初次全髋关节置换术患者,按体重指数<40与≥40 kg/m2分层。结果显示病态肥胖患者再入院、再手术和感染并发症的比值比显著更高,但病态肥胖患者再入院率以及非病态肥胖患者再入院和再手术率在研究期间有所改善,输血减少是总体并发症率改善的主要原因。

要点

  • 2011至2019年共234,334例初次全髋关节置换术,其中16,979例(7.8%)体重指数≥40 kg/m2。
  • 体重指数≥40 kg/m2患者再入院、再手术和感染并发症的比值比显著更高。
  • 研究期间体重指数<40 kg/m2患者再入院和再手术率以及体重指数>40 kg/m2患者再入院率有所改善。

核心结论

  • 2011至2019年,非病态肥胖患者的再入院和再手术比值比以及病态肥胖患者的再入院比值比有所改善。
  • 输血减少是总体并发症率改善的主要原因。
  • 尽管病态肥胖患者并发症风险仍较高,但病态肥胖与非病态肥胖患者之间的结局差异似乎并未扩大。

研究设计与样本

  • 回顾性分析美国外科医师学会国家外科质量改进计划数据库中2011至2019年接受初次全髋关节置换术的患者。
  • 共纳入234,334例患者,按体重指数<40 kg/m2和≥40 kg/m2分层,其中体重指数≥40 kg/m2者16,979例(7.8%)。
  • 评估30天感染并发症、再入院、再手术和任何并发症的发生率,采用比值比和多因素分析比较趋势。

主要发现

  • 体重指数≥40 kg/m2患者再入院、再手术和感染并发症的比值比显著更高。
  • 任何并发症的比值比在2011年病态肥胖患者较低,2012至2014年无差异,2015至2019年较高。
  • 任何非输血并发症的比值比在病态肥胖患者更高,且研究期间两组均无改善。
  • 体重指数<40 kg/m2患者再入院和再手术率以及体重指数>40 kg/m2患者再入院率有所改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Morbidly obese patients have increased rates of complications following primary total hip arthroplasty (THA) and it is not clear whether improvements in THA care pathways are equally benefitting these patients. The purpose of this study is to assess if reductions in complications have similarly improved for both morbidly obese and non-morbidly obese patients after THA. METHODS: Patients undergoing primary THA between 2011 and 2019 were identified in the American College of Surgeons National Surgical Quality Improvement Program database. Patients were stratified by body mass index (BMI) <40 and ≥40 kg/m2. Thirty-day rates of infectious complications, readmissions, reoperation, and any complication were assessed. Trends in complications were compared utilizing odds ratios and multivariate analyses. RESULTS: In total, 234,334 patients underwent THA and 16,979 (7.8%) had BMI ≥40 kg/m2. Patients with BMI ≥40 kg/m2 were at significantly higher odds for readmission, reoperation, and infectious complications. Odds for any complication were lower for morbidly obese patients in 2011, not different from 2012 to 2014, and higher from 2015 to 2019 compared to lower BMI patients. Odds for any non-transfusion complication were higher for morbidly obese patients and there was no improvement for either group over the study period. There were improvements in rates of readmission and reoperation for patients with BMI <40 kg/m2 and readmission for BMI >40 kg/m2. CONCLUSION: Odds for readmission and reoperation for non-morbidly obese patients and readmission for morbidly obese patients improved from 2011 to 2019. Reductions in transfusions are largely responsible for improvements in overall complication rates. Although morbidly obese patients remain at higher risk for complications, there does not appear to be a growing disparity in outcomes between morbidly obese and non-morbidly obese patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. DeMik DE, Carender CN, Glass NA, et al. Are Morbidly Obese Patients Equally Benefitting From Care Improvements in Total Hip Arthroplasty? J Arthroplasty. 2021. PMID: 34883253. doi:10.1016/j.arth.2021.11.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。